Alex Belov
Developers by oneinveststock.com. Analyst, investor
Johnson & Johnson (JNJ) Stock Price Today, Real-Time Quotes, Forecasts
Johnson & Johnson (JNJ) Stock: Real Time Chart and Quotes
Stock Consensus Rating = "Outperform"
Lowest Price Target
$168.00
Average target price
$182.00
Maximum target price
$205.00
J&J
JNJ
Stock = Johnson & Johnson
ISIN = US4592001014
About company = Johnson & Johnson is a holding company that specializes in the research, development, production and sale of healthcare products.
Johnson & Johnson (JNJ) Stock Forecasts, Predictions
On January 25, 2023 analytical firm “Atlantic Equities” published a latest price target for Johnson & Johnson (JNJ) stock of $168,00 for the next 12 months. 28 analyst firms have released forecasts for Johnson & Johnson (JNJ) stock over the past year. The consensus rating of analytical firms is “Outperform”. The average analyst price target is $182,00 over the next 12 months. See the table below for the latest price targets and analyst forecasts for Johnson & Johnson (JNJ) shares.
Johnson & Johnson (JNJ) Latest Price Targets
| Forecast date | Analytical firm | Change target price | Rating |
|---|---|---|---|
| 01/25/2023 | Atlantic Equities | $160→$168 | Neutral |
| 01/25/2023 | Morgan Stanley | $176→$180 | Equal-Weight |
| 01/20/2023 | SVB Leerink | $194→$186 | Outperform |
| 12/12/2022 | Citigroup | $198→$205 | Buy |
| 12/06/2022 | Morgan Stanley | $178→$176 | Equal-Weight |
| 12/01/2022 | Morgan Stanley | $170→$178 | Equal-Weight |
| 11/18/2022 | Credit Suisse | $170 | Neutral |
| 10/19/2022 | Atlantic Equities | $165→$160 | Neutral |
| 10/19/2022 | Morgan Stanley | $174→$170 | Equal-Weight |
| 10/19/2022 | Raymond James | $192→$185 | Outperform |
| 10/18/2022 | Barclays | $175 | Equal-Weight |
| 10/12/2022 | Morgan Stanley | $173→$174 | Equal-Weight |
| 09/12/2022 | Morgan Stanley | $174→$173 | Equal-Weight |
| 07/21/2022 | UBS | $185→$180 | Neutral |
| 07/20/2022 | Citigroup | $205→$201 | Buy |
| 07/20/2022 | SVB Leerink | $200→$194 | Outperform |
| 07/20/2022 | Raymond James | $196→$192 | Outperform |
| 07/20/2022 | Atlantic Equities | $174→$165 | Neutral |